Tag: remedies

CMA Extends Getty-Shutterstock Merger Probe

The United Kingdom’s Competition and Markets Authority (CMA) has officially extended its…

Airbus-Thales-Leonardo Need OHB, SES, and Indra’s Nods To Clear JV

The race to create a European "Space Champion" is about to enter…

Paramount-WBD: Financial and Antitrust Analysis

Paramount’s executives expect a relatively easy regulatory review, with a closing within…

CAT Trial Commences: Spreadex Challenges CMA Over “Monopoly” Divestiture Order

LONDON — The Competition Appeal Tribunal (CAT) today began a high-stakes trial…

Visa’s Acquisition of Prosa Mexico Hangs in the Balance

Visa’s proposed acquisition of a majority stake in Prosa, the country’s leading…

Spain’s CNMC Clears Oximesa–Esteve Teijin Deal with Remedies

Spain’s competition authority, the CNMC, has approved Oximesa’s acquisition of sole control…

Deutsche Börse-Allfunds €5.3B Deal is a Phase II Candidate With Remedies in Sight

On January 21, 2026, Deutsche Börse Group (DBG) and Allfunds Group plc…

Belgium Approves Delhaize’s Acquisition of Delfood—With Strings Attached

The Belgian Competition Authority (BCA) has officially cleared Delhaize’s acquisition of Delfood,…

Televisa is Buying AT&T, and Regulators Won’t Stop It

AT&T is leaving Mexico, and Grupo Televisa (Izzi/Sky) is the frontrunner to…

UK Reviews Competition Rules to Ease Business Burden

The UK’s Competition and Markets Authority is reassessing a range of market…

Netflix’s Debt on WBD Demands Price Hikes, Leading to Regulatory Clash

Netflix faces an uphill road to close the WBD deal, from convincing…

Telefónica-Vodafone: Financial & Regulatory Analysis

Telefónica continues with its strategic ambition to acquire Vodafone Spain, aiming to…